M. Taneda

Immunochemical studies for the presence of P-450 HFLa, a form of cytochrome P-450 in human fetal livers in human hepatocellular carcinoma cells.

T. Kamataki, K. Tsukidate, M. Komori, 1989, Journal of pharmacobio-dynamics.

Metabolism of TC-81, a new dihydropyridine calcium entry blocker, in rats and dogs

H. Tanabe, Hiroaki Sato, H. Arizono, 1992 .

Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens

T. Kamataki, M. Kitada, K. Itahashi, 1991, Japanese journal of cancer research : Gann.

Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers.

M. Nagao, T. Kamataki, M. Komori, 1989, Mutation research.

Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and fetal livers.

T. Kamataki, M. Kitada, K. Nagashima, 1990, Cancer research.

Comparative biochemistry of cytochrome P-450 species responsible for the activation of mutagenic food-derived heterocyclic amines

T. Kamataki, M. Komori, T. Uchida, 1991 .